Loading…
Agappe Diagnostics Ltd inaugurated a new 100,000 sq ft equipment manufacturing facility at Infopark, Kerala, and unveiled the first 'Make in India' In-Vitro Biomarkers using CLEIA technology developed with Fujirebio Holdings.
Fujirebio, a subsidiary of H.U. Group Holdings, acquired ADx NeuroSciences NV for 40 million euros. ADx NeuroSciences becomes a wholly owned subsidiary of Fujirebio Europe NV. The deal is expected to close in July 2022.